Rethinking IPF care: charting the course to person-centred integrated care for idiopathic pulmonary fibrosis together with patients and healthcare professionals KU Leuven
Idiopathic pulmonary fibrosis (IPF) is a rare lung disease that has a crude impact on a person's ability to breathe freely due to the progressive accumulation of scar tissue which destructs lung tissue. As a result, patients face debilitating symptoms such as breathlessness and fatigue, and are given a poor prognosis of two to five years after diagnosis if left untreated. Fortunately, there are two anti-fibrotic drugs available that ...